Daniel Neureiter

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 30

Top Topics

Helicobacter Pylori Infection

Top Venues

International journal of molecular sciences

Expert opinion on investigational drugs

Antioxidants (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Florian Primavesi, Thomas Senoner, Sophie Schindler, Aleksandar Nikolajevic, Pietro Di Fazio, Georg Csukovich, Silvia Eller, Bettina Neumayer, Markus Anliker, Eva Braunwarth, Rupert Oberhuber, Thomas Resch, Manuel Maglione, Benno Cardini, Thomas Niederwieser, Silvia Gasteiger, Eckhard Klieser, Herbert Tilg, Stefan Schneeberger, Daniel Neureiter, Dietmar Öfner-Velano, Jakob Troppmair, Stefan Stättner
The Interplay between Perioperative Oxidative Stress and Hepatic Dysfunction after Human Liver Resection: A Prospective Observational Pilot Study. Antioxidants (Basel, Switzerland) 13 (5) (2024)
Marina Canadas-Ortega, Iris Mühlbacher, Gernot Posselt, Sebastian Diechler, Christian Daniel Ferner, Francesco Boccellato, Oliver Owen Koch, Daniel Neureiter, Michael Weitzendorfer, Klaus Emmanuel, Silja Wessler
HtrA-Dependent E-Cadherin Shedding Impairs the Epithelial Barrier Function in Primary Gastric Epithelial Cells and Gastric Organoids. International journal of molecular sciences 25 (13) (2024)
Marina Canadas-Ortega, Iris Mühlbacher, Gernot Posselt, Sebastian Diechler, Christian Daniel Ferner, Francesco Boccellato, Oliver Owen Koch, Daniel Neureiter, Michael Weitzendorfer, Klaus Emmanuel, Silja Wessler
HtrA-Dependent E-Cadherin Shedding Impairs the Epithelial Barrier Function in Primary Gastric Epithelial Cells and Gastric Organoids. International journal of molecular sciences 25 (13) (2024)
Dominik Kiem, Matthias Ocker, Richard Greil, Daniel Neureiter, Thomas Melchardt
Enhancing anti-CD274 (PD-L1) targeting through combinatorial immunotherapy with bispecific antibodies and fusion proteins: from preclinical to phase II clinical trials. Expert opinion on investigational drugs 33 (3) (2024)
Dominik Kiem, Matthias Ocker, Richard Greil, Daniel Neureiter, Thomas Melchardt
Enhancing anti-CD274 (PD-L1) targeting through combinatorial immunotherapy with bispecific antibodies and fusion proteins: from preclinical to phase II clinical trials. Expert opinion on investigational drugs (2024)
Theresa Neuper, Tobias Frauenlob, Hieu-Hoa Dang, Peter William Krenn, Gernot Posselt, Christof Regl, Nikolaus Fortelny, Veronika Bednárová, Michael S Unger, Gunda Üblagger, Daniel Neureiter, Iris Mühlbacher, Michael Weitzendorfer, Franz Singhartinger, Klaus Emmanuel, Christian G Huber, Silja Wessler, Fritz Aberger, Jutta Horejs-Hoeck
ADP-heptose attenuates Helicobacter pylori -induced dendritic cell activation. Gut microbes 16 (1) (2024)
Florian Primavesi, Thomas Senoner, Sophie Schindler, Aleksandar Nikolajevic, Pietro Di Fazio, Georg Csukovich, Silvia Eller, Bettina Neumayer, Markus Anliker, Eva Braunwarth, Rupert Oberhuber, Thomas Resch, Manuel Maglione, Benno Cardini, Thomas Niederwieser, Silvia Gasteiger, Eckhard Klieser, Herbert Tilg, Stefan Schneeberger, Daniel Neureiter, Dietmar Öfner-Velano, Jakob Troppmair, Stefan Stättner
The Interplay between Perioperative Oxidative Stress and Hepatic Dysfunction after Human Liver Resection: A Prospective Observational Pilot Study. Antioxidants (Basel, Switzerland) 13 (5) (2024)
Marina Canadas-Ortega, Iris Mühlbacher, Gernot Posselt, Sebastian Diechler, Christian Daniel Ferner, Francesco Boccellato, Oliver Owen Koch, Daniel Neureiter, Michael Weitzendorfer, Klaus Emmanuel, Silja Wessler
HtrA-Dependent E-Cadherin Shedding Impairs the Epithelial Barrier Function in Primary Gastric Epithelial Cells and Gastric Organoids. International journal of molecular sciences 25 (13) (2024)
Dominik Kiem, Matthias Ocker, Richard Greil, Daniel Neureiter, Thomas Melchardt
Enhancing anti-CD274 (PD-L1) targeting through combinatorial immunotherapy with bispecific antibodies and fusion proteins: from preclinical to phase II clinical trials. Expert opinion on investigational drugs 33 (3) (2024)
Tarkan Jäger, Philipp Schredl, Daniel Neureiter, Jaroslav Presl, Peter Tschann, Ingmar Königsrainer, Andreas Pascher, Klaus Emmanuel, Stephan Regenbogen, Jan Philipp Ramspott
The SAlzburg PEritoneal SUrface CAlculator (SAPESUCA): The First Web-Based Application for Peritoneal Surface Area Quantification. Cancers 15 (12) (2023)
Dino Bekric, Daniel Neureiter, Celina Ablinger, Heidemarie Dobias, Marlena Beyreis, Markus Ritter, Martin Jakab, Johannes Bischof, Ulrich Koller, Tobias Kiesslich, Christian Mayr
Evaluation of Tazemetostat as a Therapeutically Relevant Substance in Biliary Tract Cancer. Cancers 15 (5) (2023)
Tarkan Jäger, Philipp Schredl, Daniel Neureiter, Jaroslav Presl, Peter Tschann, Ingmar Königsrainer, Andreas Pascher, Klaus Emmanuel, Stephan Regenbogen, Jan Philipp Ramspott
The SAlzburg PEritoneal SUrface CAlculator (SAPESUCA): The First Web-Based Application for Peritoneal Surface Area Quantification. Cancers 15 (12) (2023)
Eckhard Klieser, Bettina Neumayer, Pietro Di Fazio, Christian Mayr, Daniel Neureiter, Tobias Kiesslich
HDACs as an emerging target in endocrine tumors: a comprehensive review. Expert review of endocrinology & metabolism (2023)
Dino Bekric, Daniel Neureiter, Celina Ablinger, Heidemarie Dobias, Marlena Beyreis, Markus Ritter, Martin Jakab, Johannes Bischof, Ulrich Koller, Tobias Kiesslich, Christian Mayr
Evaluation of Tazemetostat as a Therapeutically Relevant Substance in Biliary Tract Cancer. Cancers 15 (5) (2023)
Peter Ellinghaus, Daniel Neureiter, Hendrik Nogai, Sebastian Stinzing, Matthias Ocker
Patient Selection Approaches in FGFR Inhibitor Trials-Many Paths to the Same End? Cells 11 (19) (2022)
Konstantin Schlick, Bettina Neumayer, Daniel Neureiter
What is the management of resected cholangiocarcinoma in terms of intra- and postoperative status of tumor margins and lymph nodes? A current view. Expert review of gastroenterology & hepatology (2022)
Nathalie Stummer, Daniel Weghuber, René Günther Feichtinger, Sara Huber, Johannes Adalbert Mayr, Barbara Kofler, Daniel Neureiter, Eckhard Klieser, Sarah Hochmann, Wanda Lauth, Anna Maria Schneider
Hydrogen Sulfide Metabolizing Enzymes in the Intestinal Mucosa in Pediatric and Adult Inflammatory Bowel Disease. Antioxidants (Basel, Switzerland) 11 (11) (2022)
Tobias Kiesslich, Daniel Neureiter
Can We Efficiently Target HDAC in Cancer? Cancers 14 (16) (2022)
Anna Maria Schneider, Mihriban Özsoy, Franz A Zimmermann, Susanne Maria Brunner, René Günther Feichtinger, Johannes Adalbert Mayr, Barbara Kofler, Daniel Neureiter, Eckhard Klieser, Elmar Aigner, Sebastian Schütz, Nathalie Stummer, Wolfgang Sperl, Daniel Weghuber
Expression of Oxidative Phosphorylation Complexes and Mitochondrial Mass in Pediatric and Adult Inflammatory Bowel Disease. Oxidative medicine and cellular longevity 2022 (2022)
Dino Bekric, Matthias Ocker, Christian Mayr, Sebastian Stinzing, Markus Ritter, Tobias Kiesslich, Daniel Neureiter
Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation. Cancers 14 (7) (2022)
Christian Mayr, Tobias Kiesslich, Dominik Paul Modest, Sebastian Stintzing, Matthias Ocker, Daniel Neureiter
Chemoresistance and resistance to targeted therapies in biliary tract cancer: what have we learned? Expert opinion on investigational drugs 31 (2) (2022)
Falk Roeder, Sabine Gerum, Stefan Hecht, Florian Huemer, Tarkan Jäger, Reinhard Kaufmann, Eckhard Klieser, Oliver Owen Koch, Daniel Neureiter, Klaus Emmanuel, Felix Sedlmayer, Richard Greil, Lukas Weiss
How We Treat Localized Rectal Cancer-An Institutional Paradigm for Total Neoadjuvant Therapy. Cancers 14 (22) (2022)
Christian Mayr, Tobias Kiesslich, Sara Erber, Dino Bekric, Heidemarie Dobias, Marlena Beyreis, Markus Ritter, Tarkan Jäger, Bettina Neumayer, Paul Winkelmann, Eckhard Klieser, Daniel Neureiter
HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin as a Promising Epigenetic Drug for Biliary Tract Cancer. Cancers 13 (15) (2021)
Dominik Kiem, Michael Leisch, Daniel Neureiter, Theresa Haslauer, Alexander Egle, Thomas Melchardt, Max S Topp, Richard Greil
Two Cases of Pancytopenia with Coombs-Negative Hemolytic Anemia after Chimeric Antigen Receptor T-Cell Therapy. International journal of molecular sciences 22 (11) (2021)
Andrej Wagner, Stephan Zandanell, Tobias Kiesslich, Daniel Neureiter, Eckhard Klieser, Josef Holzinger, Frieder Berr
Systematic Review on Optical Diagnosis of Early Gastrointestinal Neoplasia. Journal of clinical medicine 10 (13) (2021)
Daniel Neureiter, Christian Mayr, Tobias Kiesslich
The challenges of combinatory immunotherapy for biliary tract cancer. Expert opinion on investigational drugs 30 (6) (2021)
Markus Steiner, Franz Josef Gassner, Thomas Parigger, Daniel Neureiter, Alexander Egle, Roland Geisberger, Richard Greil, Nadja Zaborsky
A POLE Splice Site Deletion Detected in a Patient with Biclonal CLL and Prostate Cancer: A Case Report. International journal of molecular sciences 22 (17) (2021)
Matthias Ocker, Daniel Neureiter
Predicting the outcome of patients with hepatocellular carcinoma: new approaches beyond established clinical scoring systems. Expert review of gastroenterology & hepatology 15 (2) (2020)
Wiebke Solass, Christine Sempoux, Norman John Carr, Frederic Bibeau, Daniel Neureiter, Tarkan Jäger, Tina Di Caterino, Christophe Brunel, Eckhard Klieser, Claus W Fristrup, Michael B Mortensen, Sönke Detlefsen
Reproducibility of the peritoneal regression grading score for assessment of response to therapy in peritoneal metastasis. Histopathology 74 (7) (2019)
René Günther Feichtinger, Daniel Neureiter, Tom Skaria, Silja Wessler, Timothy L Cover, Johannes Adalbert Mayr, Franz A Zimmermann, Gernot Posselt, Wolfgang Sperl, Barbara Kofler
Oxidative Phosphorylation System in Gastric Carcinomas and Gastritis. Oxidative medicine and cellular longevity 2017 (2017)